Advertisement
Screener

NeoGenomics, Inc. (NEO) Material Contracts, 2022

NeoGenomics, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2022-12-06: Form 8-K; Exhibit 10.1; Description Employment Agreement of Jeffrey S. Sherman, dated December 5, 2022..
  • 2022-11-08: Form 10-Q; Exhibit 10.2; Description Amendment to Employment Agreement, dated August 15, 2022, by and between NeoGenomics, Inc. and Christopher Smith..
  • 2022-11-08: Form 10-Q; Exhibit 10.1; Description Retention Agreement, dated October 19, 2022, by and between NeoGenomics, Inc. and Cynthia Dieter..
  • 2022-07-21: Form 8-K; Exhibit 10.1; Description Employment Agreement, executed July 20, 2022, by and between NeoGenomics, Inc. and Christopher Smith..
FiledFormExhibitDescription
2022-12-068-K10.1Employment Agreement of Jeffrey S. Sherman, dated December 5, 2022.
2022-11-0810-Q10.2Amendment to Employment Agreement, dated August 15, 2022, by and between NeoGenomics, Inc. and Christopher Smith.
2022-11-0810-Q10.1Retention Agreement, dated October 19, 2022, by and between NeoGenomics, Inc. and Cynthia Dieter.
2022-07-218-K10.1Employment Agreement, executed July 20, 2022, by and between NeoGenomics, Inc. and Christopher Smith.
2022-07-188-K/A10.1Settlement Agreement, dated as of July 11, 2022, by and between Inivata Limited and Clive Morris.
2022-05-0910-Q10.2Executive Chair and Principal Executive Officer agreement between NeoGenomics, Inc. and Lynn A. Tetrault dated April 25, 2022.
2022-03-288-K10.1Separation Agreement, dated as of March 28, 2022, by and between NeoGenomics, Inc. and Mark Mallon.
2022-02-2510-K10.11Form of Executive Employment Agreement between NeoGenomics, Inc. and each of its executive officers.

Similar stocks

Stock NameCountryMarket CapPE Ratio
20/20 Biolabs, Inc. (AIDX)United States$0.005B